Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 Muscle Recovery: Dose Comparison

Grade 1 muscle strain 200–300mcg daily subQ 3–5 days (inflammation reduction) 10–14 days (fiber continuity restored) Return to pain-free range of motion Peptide accelerates inflammation resolution but doesn't bypass the myofiber regeneration timeline. Expect f

This comparison does not assign a generated winner or score.

  • Grade 1 muscle strain
  • 200–300mcg daily subQ
  • 3–5 days (inflammation reduction)
  • 10–14 days (fiber continuity restored)
  • Return to pain-free range of motion
  • Peptide accelerates inflammation resolution but doesn't bypass the myofiber regeneration timeline. Expect functional improvement by week 2, not week 1
  • Grade 2 muscle tear
  • 300–500mcg daily subQ
  • 5–7 days (reduced swelling and pain)
  • 14–21 days (partial tensile strength recovery)
  • Load tolerance at 70–80% baseline
  • Angiogenesis and collagen deposition are measurable by day 14 but full remodeling requires 4–6 weeks. Peptide reduces scar tissue formation, which matters for re-injury risk
  • Tendon strain (partial tear)
  • 250–400mcg daily subQ
  • 7–10 days (reduced pain on loading)
  • 21–28 days (measurable strength improvement)
  • Biomechanical tensile strength testing
  • BPC-157 shows the strongest evidence base for tendon repair. Upregulation of Type I collagen and reduced fibrosis translate to better long-term outcomes than muscle injuries
  • Ligament sprain (Grade 2)
  • 5–7 days (reduced joint instability sensation)
  • 28–42 days (restored mechanical stability)
  • Joint laxity measurement under stress
  • Symptom relief appears faster than structural healing. The peptide's anti-inflammatory effect reduces pain before ligament architecture is fully restored
  • Chronic tendinopathy
  • 10–14 days (reduced pain during activity)
  • 4–8 weeks (collagen remodeling and reduced calcification)
  • Ultrasound imaging of tissue structure
  • Chronic injuries require longer protocols. The peptide's effect on fibroblast activity and neovascularization becomes measurable only after sustained daily administration
More references

Related material